-
Reply Ophthalmology (IF 13.7) Pub Date : 2024-04-01 Ingrid U. Scott MD MPH, Neal L. Oden PhD, Paul C. VanVeldhuisen PhD, Michael S. Ip MD, Barbara A. Blodi MD
-
Re: Scott et al.: SCORE2 Report 24: Nonlinear relationship of retinal thickness and visual acuity in central retinal and hemiretinal vein occlusion. (Ophthalmology. 2023;130:1066–1072) Ophthalmology (IF 13.7) Pub Date : 2024-04-01 Peng Wu MD, Rongyu Gao MD, Guangsen Liu MD
-
Five-Year Clinical Trial of Low-concentration Atropine for Myopia Progression (LAMP) Study: Phase 4 Report Ophthalmology (IF 13.7) Pub Date : 2024-03-16 Xiu Juan Zhang PhD, Yuzhou Zhang PhD, Benjamin H.K. Yip PhD, Ka Wai Kam MSc, Fangyao Tang PhD, Xiangtian Ling MMed, Mandy P.H. Ng MHM, Alvin L. Young MMedSc, Pei-Chang Wu MD, Clement C. Tham BM BCh, Li Jia Chen PhD, Chi Pui Pang DPhil, Jason C. Yam MD MPH
To evaluate (1) the long-term efficacy of low-concentration atropine over 5 years, (2) the proportion of children requiring retreatment and associated factors (3) the efficacy of (PRN) retreatment using 0.05% atropine from year 3 to 5. A randomized, double-masked extended trial. Children aged 4–12 years originally from the Low-Concentration Atropine for Myopia Progression study were followed up for
-
Dexamethasone Intracanalicular Insert for Clinically Significant Aqueous-Deficient Dry Eye: A Randomized Controlled Trial Ophthalmology (IF 13.7) Pub Date : 2024-03-15 Michael Lin BA, Lee Guo OD, Ian J. Saldanha MBBS MPH PhD, Shanna VanCourt MS, Julia Zeng BS, Sezen Karakus MD, Michelle Hessen OD, Gavin Li BS, Esen K. Akpek MD
To evaluate a commercially available dexamethasone intracanalicular insert to treat dry eye. Single-center, double-masked, randomized controlled trial. Patients with clinically significant aqueous-deficient dry eye [combined ocular surface staining score ≥3 (0-12), corneal fluorescein staining ≥2 (0-6), and Schirmer’s wetting <10 mm at 5 minutes in both eyes] with symptoms (dryness, eye discomfort
-
An Evaluation of the Efficacy and Safety of Timolol Maleate 0.5% Microdrops Administered with the Nanodropper® Ophthalmology (IF 13.7) Pub Date : 2024-03-14 Jennifer S. Steger PhD, Indira Durai MD, Annamalai Odayappan MD, Ramalakshmi Raman MsC, Talla Sruthi MD, Allisa J. Song BS, George Puthuran MD, Rengaraj Venkatesh MD, Elizabeth Colantuoni PhD, Alan L. Robin MD
Examine if 12.5 μL timolol maleate 0.5% microdrops dispensed with the Nanodropper® Adaptor provide non-inferior intraocular pressure (IOP) reduction compared to conventional, 28 μL drops in open-angle glaucoma (OAG) and ocular hypertension (OHT) patients. Prospective, non-inferiority, parallel, multicenter, single-masked, active-controlled, randomized trial. Treatment-naïve subjects that were recently
-
Medial Canthal Collision Tumor with Seborrheic Keratosis Hiding Underlying Basal Cell Carcinoma Ophthalmology (IF 13.7) Pub Date : 2024-03-08 Wenyu Deng MD, Jodi Sassoon MD, Roman Shinder MD FACS
-
Ocular Mucous Membrane Pemphigoid: The Effect of Risk Factors at Presentation on Treatment Outcomes Ophthalmology (IF 13.7) Pub Date : 2024-03-06 Raul E. Ruiz-Lozano MD, Maria F. Colorado-Zavala MD, Eugenia M. Ramos-Dávila MD, Manuel E. Quiroga-Garza MD, Nadim S. Azar MD, Hazem M. Mousa MD, Julio C. Hernández-Camarena MD PhD, Sandra S. Stinnett DrPH, Melissa Daluvoy MD, Terry Kim MD, Maite Sainz-de-la-Maza MD, Russell P. Hall 3rd MD, Alejandro Rodriguez-Garcia MD, Victor L. Perez MD
Analyze the influence of risk factors at presentation in the long-term immunosuppressive therapy (IMT) outcomes of ocular mucous membrane pemphigoid (OMMP). Retrospective multicenter study. Patients with OMMP seen at the Duke Eye Center, Tecnologico de Monterrey, and Hospital Clinic of Barcelona from 1990 to 2022. Data at presentation on demographics, direct immunofluorescence, ocular findings, sites
-
Phase 3 Randomized Clinical Trial of the Safety and Efficacy of Travoprost Intraocular Implant in Patients with Open-Angle Glaucoma or Ocular Hypertension Ophthalmology (IF 13.7) Pub Date : 2024-02-27 Steven R. Sarkisian, Robert E. Ang, Andy M. Lee, John P. Berdahl, Sebastian B. Heersink, James H. Burden, Long V. Doan, Kerry G. Stephens, Angela C. Kothe, Dale W. Usner, L. Jay Katz, Tomas Navratil
Evaluate the safety and intraocular pressure (IOP)-lowering efficacy of two models of the travoprost intraocular implant (fast-eluting [FE-implant] and slow eluting [SE-implant]) from one of two pivotal trials (GC-010). Phase 3, multicenter, randomized, double-masked, sham-controlled, non-inferiority trial. Subjects with open-angle glaucoma or ocular hypertension, using 0 to 3 IOP-lowering medications
-
The Risk of Optic Neuritis following mRNA Coronavirus Disease 2019 Vaccination Compared to Coronavirus Disease 2019 Infection and Other Vaccinations Ophthalmology (IF 13.7) Pub Date : 2024-02-24 Priya Shukla BS, Neha Sharma BA MPH, Jacqueline K. Shaia MS, Devon A. Cohen MD, Rishi P. Singh MD, Katherine E. Talcott MD
To determine the risk of optic neuritis (ON) after mRNA Coronavirus Disease 2019 (COVID-19) vaccine administration. U.S. National aggregate database retrospective cohort study. Patients were placed into cohorts based on mRNA COVID-19 vaccination status (no vaccine and positive history of COVID-19 infection, 1 vaccine, or 2 vaccines received) from December 2020 to June 2022. Two control cohorts were
-
-
-
-
-
-
-
-
Severe, Rebound Mpox in an Immunocompromised Man Ophthalmology (IF 13.7) Pub Date : 2024-02-19 Adam J. Neuhouser, Alisha Kamboj
-
Pleomorphic Adenoma Misdiagnosed as Chalazion Ophthalmology (IF 13.7) Pub Date : 2024-02-19 Ruimiao Li, Mingyu Ren, Limin Liu
-
TENAYA and LUCERNE: Two-Year Results from the Phase 3 Neovascular Age-Related Macular Degeneration Trials of Faricimab with Treat-and-Extend Dosing in Year 2 Ophthalmology (IF 13.7) Pub Date : 2024-02-19 Arshad M. Khanani MD MA, Aachal Kotecha PhD, Andrew Chang MBBS PhD, Shih-Jen Chen MD, Youxin Chen MD, Robyn Guymer MBBS PhD, Jeffrey S. Heier MD, Frank G. Holz MD, Tomohiro Iida MD, Jane A. Ives MSc, Jennifer I. Lim MD, Hugh Lin MD MBA, Stephan Michels MD MBA, Carlos Quezada Ruiz MD FASRS, Ursula Schmidt-Erfurth MD, David Silverman MSc MBChB, Rishi Singh MD FASRS, Balakumar Swaminathan MSc, Jeffrey
To evaluate 2-year efficacy, durability, and safety of the bispecific antibody faricimab, which inhibits both angiopoietin-2 and VEGF-A. TENAYA ( identifier, ) and LUCERNE ( identifier, ) were identically designed, randomized, double-masked, active comparator-controlled phase 3 noninferiority trials. Treatment-naive patients with neovascular age-related macular degeneration (nAMD) 50 years of age or
-
Optic Disc Melanocytoma: Apparent Shrinkage after Posterior Vitreous Detachment Ophthalmology (IF 13.7) Pub Date : 2024-02-16 Michael Balas, Mark Mandell, Parnian Arjmand
-
A Remote Consult Retinal Artery Occlusion Diagnostic Protocol Ophthalmology (IF 13.7) Pub Date : 2024-02-13 Gareth M.C. Lema, Reade De Leacy, Michael G. Fara, Robin N. Ginsburg, Alexander Barash, Bryana Banashefski, James C. Tsai, Richard B. Rosen
To report a novel protocol for diagnosis of retinal artery occlusions at the point of care using OCT and a remote consult model. Retrospective case series and evaluation of a diagnostic test or technology. Adult patients who presented with painless monocular vision loss and were diagnosed with a nonarteritic retinal artery occlusion. OCT machines were placed in the stroke center or emergency department
-
Relationship between Intraocular Pressure Fluctuation and Visual Field Progression Rates in the United Kingdom Glaucoma Treatment Study Ophthalmology (IF 13.7) Pub Date : 2024-02-13 Alessandro Rabiolo MD, Giovanni Montesano MD, David P. Crabb PhD, David F. Garway-Heath MD FRCOphth, United Kingdom Glaucoma Treatment Study Investigators, David F. Garway-Heath MD, David P. Crabb PhD, Catey Bunce DSc, Gerassimos Lascaratos MSc, Francesca Amalfitano BSc, Nitin Anand MD, Augusto Azuara-Blanco PhD, Rupert R. Bourne MD, David C. Broadway MD, Ian A. Cunliffe FRCOphth, Jeremy P. Diamond
To investigate whether intraocular pressure (IOP) fluctuation is associated independently with the rate of visual field (VF) progression in the United Kingdom Glaucoma Treatment Study. Randomized, double-masked, placebo-controlled multicenter trial. Participants with ≥5 VFs (213 placebo, 217 treatment). Associations between IOP metrics and VF progression rates (mean deviation [MD] and five fastest
-
Blepharitis Preferred Practice Pattern® Ophthalmology (IF 13.7) Pub Date : 2024-02-13 Amy Lin MD, Sumayya Ahmad MD, Guillermo Amescua MD, Albert Y. Cheung MD, Daniel S. Choi MD, Vishal Jhanji MD FRCS FRCOphth, Shahzad I. Mian MD, Michelle K. Rhee MD, Elizabeth T. Viriya MD, Francis S. Mah MD, Divya M. Varu MD, American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Panel
-
Bacterial Keratitis Preferred Practice Pattern® Ophthalmology (IF 13.7) Pub Date : 2024-02-13 Michelle K. Rhee MD, Sumayya Ahmad MD, Guillermo Amescua MD, Albert Y. Cheung MD, Daniel S. Choi MD, Vishal Jhanji MD FRCS FRCOphth, Amy Lin MD, Shahzad I. Mian MD, Elizabeth T. Viriya MD, Francis S. Mah MD, Divya M. Varu MD, American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Panel
-
Reply Ophthalmology (IF 13.7) Pub Date : 2024-02-12 Shreya A. Shah, Linus Amarikwa, Connie M. Sears, Kevin D. Clauss, Raneem D. Rajjoub, Julia Y. Kang, Madhura A. Tamhankar, César A. Briceño, Andrew R. Harrison, Kimberly P. Cockerham, Sara T. Wester, Raymond S. Douglas, Chrysoula Dosiou, Andrea L. Kossler
-
Dry Eye Syndrome Preferred Practice Pattern® Ophthalmology (IF 13.7) Pub Date : 2024-02-12 Guillermo Amescua MD, Sumayya Ahmad MD, Albert Y. Cheung MD, Daniel S. Choi MD, Vishal Jhanji MD FRCS FRCOphth, Amy Lin MD, Shahzad I. Mian MD, Michelle K. Rhee MD, Elizabeth T. Viriya MD, Francis S. Mah MD, Divya M. Varu MD, American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Panel
-
Adult Strabismus Preferred Practice Pattern® Ophthalmology (IF 13.7) Pub Date : 2024-02-12 Linda R. Dagi MD, Federico G. Velez MD, Jonathan M. Holmes MD, Steven M. Archer MD, Mitchell B. Strominger MD, Stacy L. Pineles MD, Evelyn A. Paysse MD, Matthew Simon Pihlblad MD, Hatice Tuba Atalay MD, Brian N. Campolattaro MD, Yoon-Hee Chang MD PhD, American Academy of Ophthalmology Preferred Practice Pattern Adult Strabismus Panel
-
Corneal Edema and Opacification Preferred Practice Pattern® Ophthalmology (IF 13.7) Pub Date : 2024-02-12 Shahzad I. Mian MD, Elizabeth T. Viriya MD, Sumayya Ahmad MD, Guillermo Amescua MD, Albert Y. Cheung MD, Daniel S. Choi MD, Vishal Jhanji MD FRCS FRCOphth, Amy Lin MD, Michelle K. Rhee MD, Francis S. Mah MD, Divya M. Varu MD, American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Panel
-
Corneal Ectasia Preferred Practice Pattern® Ophthalmology (IF 13.7) Pub Date : 2024-02-12 Vishal Jhanji MD FRCS FRCOphth, Sumayya Ahmad MD, Guillermo Amescua MD, Albert Y. Cheung MD, Daniel S. Choi MD, Amy Lin MD, Shahzad I. Mian MD, Michelle K. Rhee MD, Elizabeth T. Viriya MD, Francis S. Mah MD, Divya M. Varu MD, American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Panel
-
Conjunctivitis Preferred Practice Pattern Ophthalmology (IF 13.7) Pub Date : 2024-02-12 Albert Y. Cheung MD, Daniel S. Choi MD, Sumayya Ahmad MD, Guillermo Amescua MD, Vishal Jhanji MD FRCS FRCOphth, Amy Lin MD, Shahzad I. Mian MD, Michelle K. Rhee MD, Elizabeth T. Viriya MD, Francis S. Mah MD, Divya M. Varu MD, American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Panel
-
Unilateral Lipemic Aqueous Ophthalmology (IF 13.7) Pub Date : 2024-02-11 Junran Sun, Yuanyuan Gong, Suqin Yu
-
Re: Shah et al.: Teprotumumab-related adverse events in thyroid eye disease: a multicenter study (Ophthalmology. 2023 Oct 16:S0161-6420(23)00760-1) Ophthalmology (IF 13.7) Pub Date : 2024-02-10 Terry J. Smith
-
Image Artifact on Swept-Source Anterior-Segment OCT after Descemet Membrane Endothelial Keratoplasty Ophthalmology (IF 13.7) Pub Date : 2024-02-10 Promporn Patarajierapun, Edmund Tsui, Simon S.M. Fung
-
Re: Margolis et al.: Six myths of the anterior segment: misunderstandings and critical thinking in ophthalmology (Ophthalmology. 2023;130:783-785) Ophthalmology (IF 13.7) Pub Date : 2024-02-10 Uma D. Chaluvadi MD FRCOphth
-
Cataract Surgery and Cognitive Benefits in the Older Person: A Systematic Review and Meta-analysis Ophthalmology (IF 13.7) Pub Date : 2024-02-08 Brian Sheng Yep Yeo MBBS, Rebecca Yi Xuan Ong MBBS, Pooja Ganasekar MBBS, Benjamin Kye Jyn Tan MBBS(Hons), Dennis Chuen Chai Seow FRCP(Ed) FAMS(Geriatric Medicine), Andrew S.H. Tsai FRCOphth MCI
This systematic review and meta-analysis aims to clarify the association of cataract surgery with cognitive impairment and dementia. The association between vision impairment and cognitive decline is well-established. However, the cognitive benefits of cataract surgery are less clear. Given the lack of cure for dementia, identifying modifiable risk factors is key in caring for patients with cognitive
-
Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity of < 20/40 Ophthalmology (IF 13.7) Pub Date : 2024-02-08 Chirag D. Jhaveri MD, Danni Liu MSPH, Maureen G. Maguire PhD, Adam R. Glassman MS, Ruben A. Grigorian MD, Lee M. Jampol MD, Ronald M. Kingsley MD, Mathew W. MacCumber MD, Daniel F. Martin MD, Raj K. Maturi MD, Gisela Velez MD MPH MA, Jennifer K. Sun MD MPH, DRCR Retina Network
To identify factors for meeting prespecified criteria for switching from bevacizumab to aflibercept in eyes with center-involved diabetic macular edema (CI-DME) and moderate vision loss initially treated with bevacizumab in DRCR Retina Network protocol AC. Post hoc analysis of data from a randomized clinical trial. Two hundred seventy participants with one or both eyes harboring CI-DME with visual
-
Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis Ophthalmology (IF 13.7) Pub Date : 2024-02-05 Euna B. Koo MD, Tiffany M. Yu, Andrew J. Layton, Steven Babineaux MS RPh, Simon Fung MD MA (Oxon)
In this claims analysis, vernal keratoconjunctivitis (VKC) patients (≤18 years) treated with immunomodulators or corticosteroids had more corneal complications and higher ophthalmic care costs versus matched non-VKC controls, indicating a need for more effective treatments.
-
Trends and Sociodemographic Patterns in Keratoconus Management 2015–2020: An American Academy of Ophthalmology IRIS® Registry Analysis Ophthalmology (IF 13.7) Pub Date : 2024-02-03 Zeba A. Syed MD, Maurizio Tomaiuolo PhD, Qiang Zhang PhD, Venkatesh Prajna MD, Leslie Hyman PhD, Christopher J. Rapuano MD, IRIS® Registry Analytic Center Consortium∗, Aaron Y. Lee MD MSCI, Cecilia S. Lee MD MS, Russ Van Gelder MD PhD, Alice Lorch MD MPH, Joan W. Miller MD, Suzann Pershing MD MS, Jeffrey Goldberg MD PhD
Investigate trends in keratoconus (KCN) treatment patterns and diagnosis age from 2015 to 2020 and evaluate sociodemographic associations with the treatment approach. Retrospective cohort study. Patients with a new KCN diagnosis from 2015 to 2020 were identified in the Academy IRIS® Registry (Intelligent Research in Sight). Associations between sociodemographic factors and treatment were evaluated
-
Association of Cutaneous Keloids, Hypertrophic Scarring, and Fibrosis with Risk of Postoperative Proliferative Vitreoretinopathy Ophthalmology (IF 13.7) Pub Date : 2024-02-01 Danny A. Mammo MD, Karen Wai MD, Ehsan Rahimy MD, Carolyn K. Pan MD, Sunil K. Srivastava MD, Prithvi Mruthyunjaya MD
To assess an association between cutaneous keloids, hypertrophic scarring, and fibrosis (KHF) and risk of postoperative proliferative vitreoretinopathy (PVR) after rhegmatogenous retinal detachment (RRD) repair. Retrospective, population-based cohort study. Patients aged ≥ 18 years who underwent initial retinal detachment (RD) repair with pars plana vitrectomy with or without scleral buckle (SB) (Current
-
Predictive Performance of an Updated Polygenic Risk Score for Age-Related Macular Degeneration Ophthalmology (IF 13.7) Pub Date : 2024-02-01 Chenglong Yu PhD, Liubov Robman MBBS PhD, Weixiong He PhD, Robyn L. Woods PhD, Le Thi Phuong Thao PhD, Rory Wolfe PhD, James Phung BBiomedSc, Galina A. Makeyeva MBBS PhD, Lauren A.B. Hodgson MPH, John J. McNeil MD PhD, Robyn H. Guymer MBBS PhD, Stuart MacGregor PhD, Paul Lacaze PhD
A recent genome-wide association study of age-related macular degeneration (AMD) identified new AMD-associated risk variants. These variants now can be incorporated into an updated polygenic risk score (PRS). This study aimed to assess the performance of an updated PRS, PRS2023, in an independent cohort of older individuals with retinal imaging data and to compare performance with an older PRS, PRS2016
-
A Retrospective Longitudinal Study of 460 Patients with ABCA4-Associated Retinal Disease Ophthalmology (IF 13.7) Pub Date : 2024-02-01 Beau J. Fenner MD PhD, S. Scott Whitmore PhD, Adam P. DeLuca PhD, Jean L. Andorf BA, Heather T. Daggett BS, Meagan A. Luse BS, Lorena M. Haefeli MD, Janet B. Riley BSN RN, Douglas B. Critser BS, Mark E. Wilkinson OD, Alina V. Dumitrescu MD, Arlene V. Drack MD, Timothy M. Boyce MD, Jonathan F. Russell MD PhD, Elaine M. Binkley MD, Elliott H. Sohn MD, Stephen R. Russell MD, H. Culver Boldt MD, Robert
To investigate the distribution of genotypes and natural history of -associated retinal disease in a large cohort of patients seen at a single institution. Retrospective, single-institution cohort review. Patients seen at the University of Iowa between November 1986 and August 2022 clinically suspected to have disease caused by sequence variations in DNA samples from participants were subjected to
-
Atypical Location of Pleomorphic Adenoma Involving the Eyelid Margin Ophthalmology (IF 13.7) Pub Date : 2024-01-27 Anthony S. Wong, Paul Phelps
Abstract not available
-
Hyporeflective Subretinal Lucency in Central Serous Chorioretinopathy Ophthalmology (IF 13.7) Pub Date : 2024-01-27 Jacques Bijon, K. Bailey Freund
Abstract not available
-
Usage of the Remained Tissues after Keratoplasty for Endothelial Keratoplasty Ophthalmology (IF 13.7) Pub Date : 2024-01-27 Xiaojuan Dong, Chen Ouyang, Ting Huang
Abstract not available
-
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials Ophthalmology (IF 13.7) Pub Date : 2024-01-26 Ramin Tadayoni MD PhD, Liliana P. Paris MD PhD, Carl J. Danzig MD, Francis Abreu PhD, Arshad M. Khanani MD MA, Christopher Brittain MBBS MBA, Timothy Y.Y. Lai MD FRCOphth, Zdenka Haskova MD PhD, Taiji Sakamoto MD PhD, Aachal Kotecha PhD, Patricio G. Schlottmann MD, Ying Liu PhD, András Seres MD, Anne-Cecile Retiere PharmD, Jeffrey R. Willis MD PhD, Young Hee Yoon MD PhD, BALATON and COMINO Investigators
To evaluate the 24-week efficacy and safety of the dual angiopoietin-2 (Ang-2) and vascular endothelial growth factor (VEGF)-A inhibitor faricimab versus aflibercept in patients with vein occlusion. Phase 3, global, randomized, double-masked, active comparator-controlled trials: BALATON/COMINO (ClincalTrials.gov identifiers: NCT04740905/NCT04740931; sites: 149/192). Patients with treatment-naïve foveal
-
Hospitalization, Overdose, and Mortality After Opioid Prescriptions Tied to Ophthalmic Surgery Ophthalmology (IF 13.7) Pub Date : 2024-01-26 Viengneesee Thao PhD MS, David A. Helfinstine Jr. MS, Lindsey R. Sangaralingham MPH, Yoshihiro Yonekawa MD, Matthew R. Starr MD
Opioid prescriptions continue to carry significant short- and long-term systemic risks, even after ophthalmic surgery. The goal of this study was to identify any association of opioid prescription, after ophthalmic surgery, with postoperative hospitalization, opioid overdose, opioid dependence, and all-cause mortality. Retrospective, cross-sectional analysis. Patients undergoing an ophthalmic surgery
-
Best Vitelliform Macular Dystrophy Natural History Study Report 1: Clinical Features and Genetic Findings Ophthalmology (IF 13.7) Pub Date : 2024-01-24 Yannik Laich MD, Michalis Georgiou MD PhD, Kaoru Fujinami MD PhD, Malena Daich Varela MD, Yu Fujinami-Yokokawa MPH, Shaima Awadh Hashem MD, Thales Antonio Cabral de Guimaraes MD, Omar A. Mahroo PhD FRCOphth, Andrew R. Webster MD(Res) FRCOphth, Michel Michaelides MD(Res) FRCOphth
To analyze the genetic findings, clinical spectrum, and natural history of Best vitelliform macular dystrophy (BVMD) in a cohort of 222 children and adults. Single-center retrospective, consecutive, observational study. Patients with a clinical diagnosis of BVMD from pedigrees with a likely disease-causing monoallelic sequence variant in the gene. Data were extracted from electronic and physical case
-
-
The Unfolding Story of Private Equity in Ophthalmology Ophthalmology (IF 13.7) Pub Date : 2024-01-19 Sylvia L. Groth, Paul Sternberg
Abstract not available
-
Intraocular Pressure Spike Following Stand-Alone Phacoemulsification in the Intelligent Research in Sight (IRIS®) Registry Ophthalmology (IF 13.7) Pub Date : 2024-01-20 Alcina K. Lidder, Elizabeth A. Vanner, Ta Chen Chang, Flora Lum, Adam L. Rothman
Objective To evaluate risk factors for intraocular pressure (IOP) spike following cataract surgery using the IRIS® Registry (Intelligent Research in Sight). Design Retrospective clinical cohort study. Subjects Adults with IRIS® Registry data who underwent stand-alone phacoemulsification from January 1, 2013 to September 30, 2019. Methods IOP spike was defined as a postoperative IOP >30 mmHg and >10
-
Before the Final Curtain: Unraveling “Tache Noire De La Sclerotique” Ophthalmology (IF 13.7) Pub Date : 2024-01-19 Stylianos A. Kandarakis, Georgia Karageorgiou, Petros Petrou
Abstract not available
-
-
This Issue at a Glance Ophthalmology (IF 13.7) Pub Date : 2024-01-19 Sandeep Ravindran
Abstract not available
-
A Simple Vista en Este Número Ophthalmology (IF 13.7) Pub Date : 2024-01-19 Sandeep Ravindran
Abstract not available
-
-
-
Glycemic Trends in Patients with Thyroid Eye Disease Treated with Teprotumumab in 3 Clinical Trials Ophthalmology (IF 13.7) Pub Date : 2024-01-20 Terry J. Smith MD, Dustin Cavida PharmD, Kate Hsu MS MBA, Sun Kim MS RAC, Qianhong Fu MS, Giuseppe Barbesino MD, Sara Tullis Wester MD, Robert J. Holt PharmD MBA, Rajib K. Bhattacharya MD
Assess incidence, severity, and glucose excursion outcomes in thyroid eye disease (TED) patients receiving the insulin-like growth factor-1 receptor inhibitor teprotumumab from 3 clinical trials. Analysis of pooled glycemic data over time. Eighty-four teprotumumab- and 86 placebo-treated active TED patients from the phase 2 and phase 3 (OPTIC) controlled clinical trials and 51 teprotumumab-treated
-
Ophthalmologic Complications in Coronavirus Disease 2019 Immunization: A National Vaccine Adverse Event Reporting System Analysis Ophthalmology (IF 13.7) Pub Date : 2024-01-18 Owais M. Aftab BS, Anup Dupaguntla BA, Patrick Hughes MD, Paul D. Langer MD, Marco A. Zarbin MD PhD, Neelakshi Bhagat MD
In this Vaccine Adverse Event Reporting System disproportionality analysis, COVID-19 immunization was rarely and generally not significantly associated with ophthalmologic complications. However, some symptoms were positive on Janssen vaccination, suggesting a need for continued investigation.
-
ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy Ophthalmology (IF 13.7) Pub Date : 2024-01-17 Emily L. Sammons MB ChB DPhil, Georgina Buck MSc, Louise J. Bowman MBBS MD, William M. Stevens MSc PhD, Imen Hammami PhD, Sarah Parish MSc DPhil, Jane Armitage FRCP FFPH, ASCEND Study Collaborative Group, Emily Sammons, Louise Bowman, William Stevens, Georgina Buck, Imen Hammami, Sarah Parish, Jane Armitage, R. Collins, J. Armitage, L. Bowman, S. Parish, R. Peto, J. Barton, D. Simpson, A. Adler, T
Preclinical studies support a protective role for aspirin in early diabetic retinopathy (DR), but the findings from randomized trials are limited. We present randomized evidence for the efficacy and safety of aspirin on DR outcomes. A substudy of the A Study of Cardiovascular Events in Diabetes (ASCEND) double-masked, randomized, placebo-controlled trial of 100 mg aspirin daily for the primary prevention
-
Lacrimal Gland Adenoid Cystic Carcinoma in a 7-year-old Boy Ophthalmology (IF 13.7) Pub Date : 2024-01-13 Tiran Golani, Gahl Greenberg, Guy Ben Simon
Abstract not available